Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
18h
Hosted on MSNMost Clozapine Prescribers Satisfied With REMS ProgramFirst approved in 1989, clozapine is the only medication indicated for treatment-resistant schizophrenia. It's also indicated ...
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, promoting… ...
A seasoned FDA compliance and regulations expert says you can watch for these major ways health intelligence may change for the public.
Morgan Stanley has upgraded Cytokinetics (CYTK) to overweight from equal weight while lowering its price target. Read more ...
Morgan Stanley (NYSE:MS) analyst Jeffrey Hung upgraded Cytokinetics (NASDAQ:CYTK) stock from Equalweight to Overweight, while ...
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results